CoChat

Efficacy of a web-based healthcare innovation to advance the quality of life and care of patients with an implantable cardioverter defibrillator (ACQUIRE-ICD): a randomized controlled trial

Open access

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index; 11 of the 18 sources its claims cite were checked for support.

Abstract

Aims: Modern clinical management of patients with an implantable cardioverter defibrillator (ICD) largely consists of remote device monitoring, although a subset is at risk of mental health issues post-implantation. We compared a 12-month web-based intervention consisting of goal setting, monitoring of patients' mental health-with a psychological intervention if needed-psychoeducational support from a nurse, and an online patient forum, with usual care on participants' device acceptance 12 months after implantation. Methods and results: This national, multi-site, two-Arm, non-blinded, randomized, controlled, superiority trial enrolled 478 first-Time ICD recipients from all 6 implantation centres in Denmark. The primary endpoint was patient device acceptance measured by the Florida Patient Acceptance Survey (FPAS; general score range = 0-100, with higher scores indicating higher device acceptance) 12 months after implantation. Secondary endpoints included symptoms of depression and anxiety. The primary endpoint of device acceptance was not different between groups at 12 months [B =-2.67, 95% confidence interval (CI) (-5.62, 0.29), P = 0.08]. Furthermore, the secondary endpoint analyses showed no significant treatment effect on either depressive [B =-0.49, 95% CI (-1.19; 0.21), P = 0.17] or anxiety symptoms [B =-0.39, 95% CI (-0.96; 0.18), P = 0.18]. Conclusion: The web-based intervention as supplement to usual care did not improve patient device acceptance nor symptoms of anxiety and depression compared with usual care. This specific web-based intervention thus cannot be recommended as a standardized intervention in ICD patients. © 2023 The Author(s). Published by Oxford University Press on behalf of the European Society of Cardiology.

Overview

CoChat Summary

## TL;DR

In this 478-patient, national randomized controlled trial of a 12-month web-based add-on to usual care for first-time ICD recipients, the intervention did not improve device acceptance at 12 months. It also did not improve depression or anxiety symptoms compared with usual care.

## Key findings

  • The primary endpoint, FPAS device acceptance at 12 months, was not significantly different between groups: B = −2.67, 95% CI (−5.62, 0.29), P = 0.08.
  • Secondary endpoints also showed no significant treatment effect on depression (B = −0.49, 95% CI (−1.19; 0.21), P = 0.17) or anxiety (B = −0.39, 95% CI (−0.96; 0.18), P = 0.18).
  • Device acceptance improved over time in both groups: from baseline to 6 months B = 4.13 (95% CI 2.61 to 5.65; P < 0.001) and to 12 months B = 5.68 (95% CI 4.16 to 7.19; P < 0.001).
  • Depression and anxiety also decreased over time in both groups, with depression falling from baseline to 6 months B = −0.75 and 12 months B = −1.04 (both P < 0.001), and anxiety falling to 6 months B = −1.17 and 12 months B = −1.60 (both P < 0.001).

## Methods

  • Design: National, multi-site, open-label, prospective, two-arm, randomized controlled superiority trial (NCT02976961), with 1:1 allocation and stratification by implantation centre and NYHA class.
  • Sample/data: 478 first-time ICD or CRT-D recipients were enrolled from all 6 ICD implanting centres in Denmark; 364 patients were eligible for the 12-month primary endpoint analysis.
  • Analysis: Modified intention-to-treat analyses used linear regression for 12-month FPAS, depression, and anxiety, adjusting for baseline scores and strata; longitudinal FPAS, depression, and anxiety were additionally modelled with linear mixed effects models.

## Limitations

  • The paper states there was uncertainty about how much participants used the web-based resources, so the intervention “dosage” likely varied across participants.
  • Patient-reported outcomes were collected from 2 days before to 2 weeks after implantation, which the authors say could create heterogeneity in baseline psychological distress measures.
  • In the intervention group, repeated monthly anxiety/depression measurement used the same questionnaires as the endpoints, which the authors say could introduce test–retest bias.
  • There was increased dropout in the intervention group; the paper notes dropouts did not differ significantly on psychological characteristics from completers.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1093/europace/euad253

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Graphical abstract
Graphical abstract CC BY-NC · PubMed Central
Figure 1 Flowchart24 of the ACQUIRE-ICD trial. ACQUIRE-ICD: a personalized and interactive web-based healthcare innovation to advance the quality of life and care of patients with an implantable cardioverter defibrillator.
Figure 1 Flowchart24 of the ACQUIRE-ICD trial. ACQUIRE-ICD: a personalized and interactive web-based healthcare innovation to advance the quality of life and care of patients with an implantable cardioverter defibrillator.CC BY-NC · PubMed Central
Figure 2 Forest plot of FPAS mean differences between intervention and control groups in pre-planned sub-group analyses. CI, confidence interval; CRT-D, implantable cardioverter defibrillator with cardiac resynchronization therapy; FPAS, Florida Patient Acceptance Survey; ICD, implantable cardioverter defibrillator; NYHA, New York Heart Association; PHQ-9, Patient Health Questionnaire-9.
Figure 2 Forest plot of FPAS mean differences between intervention and control groups in pre-planned sub-group analyses. CI, confidence interval; CRT-D, implantable cardioverter defibrillator with cardiac resynchronization therapy; FPAS, Florida Patient Acceptance Survey; ICD, implantable cardioverter defibrillator; NYHA, New York Heart Association; PHQ-9, Patient Health Questionnaire-9.CC BY-NC · PubMed Central
Figure 3 Device acceptance in first year post-implantation. CI, confidence interval; FPAS, Florida Patient Acceptance Survey.
Figure 3 Device acceptance in first year post-implantation. CI, confidence interval; FPAS, Florida Patient Acceptance Survey.CC BY-NC · PubMed Central

Verification

Claims the paper makes

10 Valid · 0 Not valid · 2 Not checked · 38 Own results and interpretations

22 more claims

Create a free account to see all 50 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 16
  • It may state two separate claims as one. 11

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Self-check results appear here once an independent check has confirmed them.

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

1 of 1

Citations

Cites

1 retracted

Show all 27 references

Cited by

See all 10

Metadata

Authors
Skov, O., Johansen, J. B., Nielsen, J. C., Larroudé, C. E., Riahi, S., Melchior, T. M., Vinther, M., Skovbakke, S. J., Rottmann, N., Wiil, U. K., Brandt, C. J., Smolderen, K. G., Spertus, J. A., & Pedersen, S. S.
Affiliations
  • University of Southern Denmark (DK)
  • Odense University Hospital (DK)
  • Aarhus University (DK)
  • Gentofte Hospital (DK)
  • Aalborg University Hospital (DK)
  • Zealand University Hospital (DK)
  • Rigshospitalet (DK)
  • Yale University (US)
  • Saint Luke's Hospital (US)
Corresponding author
Skov, Ole
Venue
Europace
Published
2023-08-21
Volume
25
Issue
12
ISSN
  • 1099-5129 (ISSN-L)
  • 1532-2092
OpenAlex
W4389448489
Cited by
10
References
27
Citations by year
2026: 1 · 2025: 7 · 2024: 2
FWCI
1.96
Type
journal article
Language
en
Open access
Locations
  • EP Europace (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion, cc-by-nc)
  • VBN Forskningsportal (Aalborg Universitet) (submittedVersion, cc-by-nc)
Funders
  • Lundbeck Foundation (R198-2015-175)
  • TrygFonden (109704)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
  • Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
Keywords
implantable cardioverter-defibrillator, online intervention, device acceptance, psychological well-being, depression, anxiety, remote device monitoring, psychological and pedagogical support, online patient forums, goal setting, quality of life
MeSH terms
Anxiety, Delivery of Health Care, Humans, Quality of Life, Surveys and Questionnaires, Defibrillators, Implantable, Internet

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy of a web-based healthcare innovation to advance the quality of life and care of patients with an implantable cardioverter defibrillator (ACQUIRE-ICD): a randomized controlled trial. https://app.cochat.ai/papers/10.1093/europace/euad253
The paper
Skov, O., Johansen, J. B., Nielsen, J. C., Larroudé, C. E., Riahi, S., Melchior, T. M., Vinther, M., Skovbakke, S. J., Rottmann, N., Wiil, U. K., Brandt, C. J., Smolderen, K. G., Spertus, J. A., & Pedersen, S. S. (2023). Efficacy of a web-based healthcare innovation to advance the quality of life and care of patients with an implantable cardioverter defibrillator (ACQUIRE-ICD): a randomized controlled trial. Europace. https://doi.org/10.1093/europace/euad253

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.